GlassScriptPhysician profile
Douglas R Murphy
NPI 1851377980
$2,112.29
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $434 · 2021: $336 · 2022: $304 · 2023: $482 · 2024: $91.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $627.73 | 2019-2024 | |
| Amgen INC. | $193.32 | 2019-2021 | |
| Pfizer INC. | $177.46 | 2019-2023 | |
| Astellas Pharma US INC | $129.56 | 2019-2024 | Myrbetriq, Veozah |
| Millicent US INC | $118.00 | 2022-2024 | Intrarosa, Femring |
| Radius Health, INC. | $100.77 | 2022-2023 | Tymlos |
| Therapeuticsmd, INC. | $96.12 | 2019-2020 | |
| Allergan, INC. | $62.78 | 2019 | |
| Organon LLC | $57.02 | 2022-2023 | Nexplanon |
| Myriad Women'S Health, INC. | $53.78 | 2023 | Bracanalysis Cdx |
| Minerva Surgical, INC | $47.70 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $40.37 | 2022-2023 | |
| Exeltis, USA INC. | $37.90 | 2021-2022 | |
| Coloplast Corp | $30.01 | 2019-2020 | |
| Lsi Solutions INC | $29.63 | 2023 | Fornisee |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $29.24 | 2021-2023 | Axonics |
| Myovant Sciences INC. | $28.73 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $28.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.53 | 2019-2020 | |
| Avion Pharmaceuticals | $23.43 | 2020 | |
| Gynesonics, INC. | $22.07 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $21.10 | 2021 | |
| Baxter Healthcare | $20.17 | 2023 | Adept |
| Ethicon US, LLC | $19.50 | 2022 | |
| Bausch Health US, LLC | $19.28 | 2020 | |
| Exact Sciences Corporation | $18.62 | 2024 | Cologuard Collection Kit |
| Covidien LP | $15.14 | 2020 | |
| Mimedx Group, INC. | $13.37 | 2024 | |
| Merck Sharp & Dohme LLC | $13.23 | 2019 | |
| Lupin INC. | $11.33 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.